Collectively, these results show that the inhibition of LAT1 leads to significant impairment of cell viability, proliferation, migration, invasion and tumor growth, as well as increased apoptosis, suggesting that LAT1 contributes to TNBC tumor growth and progression. The gene discussed is SLC7A5; the disease is neoplasm.